(Q37423736)

20 August 2017

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis (English)

1 reference

20 August 2017

0 references

1 reference

Ariane Höer

1

1 reference

20 August 2017

Cornelia Seidlitz

2

1 reference

20 August 2017

Holger Gothe

3

1 reference

20 August 2017

Guido Schiffhorst

4

1 reference

20 August 2017

Melvin Olson

5

1 reference

20 August 2017

Peyman Hadji

6

1 reference

20 August 2017

Bertram Häussler

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

3 November 2009

1 reference

Patient Preference and Adherence

20 August 2017

1 reference

20 August 2017

3

1 reference

20 August 2017

25-30

1 reference

Loss of treatment benefit due to low compliance with bisphosphonate therapy

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

Non-compliance: the Achilles' heel of anti-fracture efficacy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

Compliance with drug therapies for the treatment and prevention of osteoporosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2778431

Compliance with drug therapy for postmenopausal osteoporosis

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19936142

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

20 August 2017

PubMed publication ID

19936142

1 reference